Mission impossible: the End TB strategy

Affiliations

¹ Department of Tuberculosis, Clinical Immunology and Allergy, National Pirogov Memorial Medical University, Vinnytsia, Ukraine.
² State University of Medicine and Pharmacy 'Nicolae Testemitanu', Chisinau, Republic of Moldova.
³ Division of Clinical Infectious Diseases, Research Center Borstel, German Center for Infection Research, Clinical Tuberculosis Center, Borstel, Germany; International Health/Infectious Diseases, University of Lübeck, Lübeck, Germany; Department of Medicine, Karolinska Institute, Stockholm, Sweden. clange@fz-borstel.de.

Editorial

Andrii Dudnyk et al. Int J Tuberc Lung Dis. 2018.

. 2018 Feb 1;22(2):121-122.

doi: 10.5588/ijtld.17.0842.

¹ Department of Tuberculosis, Clinical Immunology and Allergy, National Pirogov Memorial Medical University, Vinnytsia, Ukraine.
² State University of Medicine and Pharmacy 'Nicolae Testemitanu', Chisinau, Republic of Moldova.
³ Division of Clinical Infectious Diseases, Research Center Borstel, German Center for Infection Research, Clinical Tuberculosis Center, Borstel, Germany; International Health/Infectious Diseases, University of Lübeck, Lübeck, Germany; Department of Medicine, Karolinska Institute, Stockholm, Sweden. clange@fz-borstel.de.

No abstract available

Comment on

Alarming levels of multidrug-resistant tuberculosis in Ukraine: results from the first national survey.
Pavlenko E, Barbova A, Hovhannesyan A, Tsenilova Z, Slavuckij A, Shcherbak-Verlan B, Zhurilo A, Vitek E, Skenders G, Sela I, Cabibbe AM, Cirillo DM, de Colombani P, Dara M, Dean A, Zignol M, Dadu A. Pavlenko E, et al. Int J Tuberc Lung Dis. 2018 Feb 1;22(2):197-205. doi: 10.5588/ijtld.17.0254. Int J Tuberc Lung Dis. 2018. PMID: 29506617